Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Passweg

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|June 1, 1997
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg gradeP A Rowlings, D Przepiorka, J P Klein, et al.
Blood|March 21, 1998
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study GroupR P Gale, R Hehlmann, M J Zhang, et al.
Bone Marrow Transplantation|November 6, 2007
Recent improvement in outcome of unrelated donor transplantation for aplastic anemiaR Viollier, G Socié, A Tichelli, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Bone Marrow Transplantation|April 16, 2013
Hematopoietic SCT in Europe: data and trends in 2011J R Passweg, H Baldomero, M Bregni, et al.
Bone Marrow Transplantation|March 19, 2014
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantationJ R Passweg, H Baldomero, C Peters, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 24, 2019
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, M Labopin, M Christopeit, et al.
Bone Marrow Transplantation|July 23, 1998
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemiaJ R Passweg, P A Rowlings, K A Atkinson, et al.
Bone Marrow Transplantation|April 5, 2022
Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donorsM Rüesch, S Amar El Dusouqui, E Buhrfeind, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|June 1, 1997
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg gradeP A Rowlings, D Przepiorka, J P Klein, et al.
Blood|March 21, 1998
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study GroupR P Gale, R Hehlmann, M J Zhang, et al.
Bone Marrow Transplantation|November 6, 2007
Recent improvement in outcome of unrelated donor transplantation for aplastic anemiaR Viollier, G Socié, A Tichelli, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Bone Marrow Transplantation|April 16, 2013
Hematopoietic SCT in Europe: data and trends in 2011J R Passweg, H Baldomero, M Bregni, et al.
Bone Marrow Transplantation|March 19, 2014
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantationJ R Passweg, H Baldomero, C Peters, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 24, 2019
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)J R Passweg, M Labopin, M Christopeit, et al.
Bone Marrow Transplantation|July 23, 1998
Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemiaJ R Passweg, P A Rowlings, K A Atkinson, et al.
Bone Marrow Transplantation|April 5, 2022
Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donorsM Rüesch, S Amar El Dusouqui, E Buhrfeind, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Pageof 8